Brenda McCormack
About
In The Last Decade
Brenda McCormack
21 papers receiving 720 citations
Peers
Comparison fields: 5 of 77
- Molecular Biology 417
- Pharmaceutical Science 234
- Biomaterials 194
- Immunology 189
- Organic Chemistry 68
Countries citing papers authored by Brenda McCormack
This map shows the geographic impact of Brenda McCormack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda McCormack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda McCormack more than expected).
Fields of papers citing papers by Brenda McCormack
This network shows the impact of papers produced by Brenda McCormack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda McCormack. The network helps show where Brenda McCormack may publish in the future.
Co-authorship network of co-authors of Brenda McCormack
This figure shows the co-authorship network connecting the top 25 collaborators of Brenda McCormack. A scholar is included among the top collaborators of Brenda McCormack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda McCormack. Brenda McCormack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 14 | |
| 3 | 3 | |
| 4 | 95 | |
| 5 | 67 | |
| 6 | Targeting of drugs : strategies for gene constructs and delivery | 9 |
| 7 | 106 | |
| 8 | 13 | |
| 9 | 2 | |
| 10 | 63 | |
| 11 | Vaccine design : the role of cytokine networks | 11 |
| 12 | 2 | |
| 13 | Targeting of drugs 5 : strategies for oligonucleotide and gene delivery in therapy | 12 |
| 14 | 52 | |
| 15 | 81 | |
| 16 | Vaccines : new generation immunological adjuvants | 10 |
| 17 | Targeting of drugs 4 : advances in system constructs | 8 |
| 18 | 70 | |
| 19 | 3 | |
| 20 | 11 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.